Keyphrases
Vascular Endothelial Growth Factor
100%
Vascular Endothelial Growth Factor Expression
100%
Soft Tissue Sarcoma
100%
Tumor Expression
100%
Primary Tumor
28%
Tumor Grade
28%
Recurrent Tumor
28%
Mitogen
14%
Overexpressing
14%
Epithelial Malignancies
14%
Survival Analysis
14%
Clinical Outcomes
14%
Clinical High Risk
14%
Immunostaining
14%
Anti-angiogenesis
14%
P Factor
14%
Fisher's Exact Test
14%
Tumor Samples
14%
Disease-free Survival
14%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
14%
Surgical Specimen
14%
Paraffin-embedded Tissue
14%
Disease-specific Survival
14%
High-grade Tumor
14%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
14%
Clinicopathologic Data
14%
Low-grade Tumor
14%
Hematogenous Metastasis
14%
Regulators of Angiogenesis
14%
Medicine and Dentistry
Neoplasm
100%
Vasculotropin
100%
Soft Tissue Sarcoma
100%
Primary Tumor
14%
Tumor Recurrence
14%
Tumor
14%
Angiogenesis
7%
Cancer
7%
Survival Analysis
7%
Immunohistochemistry
7%
Mitogenic Agent
7%
Biological Product
7%
Vasculotropin Antibody
7%
Fisher Exact Test
7%
Vasculotropin C
7%
Disease Free Survival
7%
Disease Specific Survival
7%
Antiangiogenic Therapy
7%
Diseases
7%
Haematogenous Metastasis
7%
Neuroscience
Vascular Endothelial Growth Factor
100%
Angiogenesis
14%
Immunohistochemistry
7%
Survival Analysis
7%
Vasculotropin Antibody
7%
Vasculotropin C
7%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Leporidae
6%
Immunostaining
6%
Angiogenesis
6%
Antiangiogenic Activity
6%
Disease Free Survival
6%
Disease Specific Survival
6%